Therefore, DMEshould be considered in type 2 diabetic patients treated with a TZD, especiallythose with peripheral edema, or other symptoms or risk factors of CHF, or concurrentlytaking exogenous insulin or nitrates.Drug cessation usually results in rapid resolution of both peripheraland macular edema [85]. The gene discussed is INS; the disease is macular retinal edema.